Paris, France – May 20, 2023 – SLTL Medical, a leading provider of interventional cardiology products, successfully concluded its participation in EuroPCR 2023. The four-day exhibition, held in Paris, France, from May 16th to 19th, 2023, was a great opportunity for SLTL Medical to exhibit its US-patented hybrid design, ultra-thin struts, and innovative drug-coating technology to a broad audience of the brightest minds in interventional cardiology.
Throughout the event, SLTL Medical’s stand was constantly busy with people interested in learning more about the company’s extensive line of top-notch medical products. The experts of SLTL were there to answer queries and give product demonstrations.
SLTL Medical showcased its PTCA Balloon Catheter and Peripheral Stent. The company’s medical team were on hand to discuss and talk about the benefits of each product and how it may be applied to ensure the most successful results for patients with the utmost precision and low complexity.
With the success of its participation in EuroPCR 2023, team SLTL Medical was thrilled. The exhibition offered the business a fantastic chance to present its top-notch medical products to a large group of professional people.
In the years to come, SLTL Medical is certain that the connections it made at EuroPCR will enable it to further built the future of cardiovascular interventions that will allow it to deliver remarkable outcomes on challenging circumstances.
“We are very pleased with the success of our participation in EuroPCR 2023,” said Dr. Arvind Patel, CMD, SLTL Group. “The exhibition was a great opportunity for us to showcase our innovative medical products to a broad audience of experts in the field of interventional cardiology. We received very positive feedback from attendees, and we are confident that our products will make a significant impact in the future of cardiovascular care.”
SLTL Medical is a leading provider of interventional cardiology products. The company’s products are used to treat a variety of cardiovascular conditions, including coronary artery disease, peripheral artery disease, and congenital heart defects. SLTL Medical is committed to providing innovative medical products that improve the lives of patients around the world.
